Performance of the FreeStyle Libre Flash glucose monitoring system in patients with type 1 and 2 diabetes mellitus
Top Cited Papers
Open Access
- 17 February 2017
- journal article
- Published by BMJ in BMJ Open Diabetes Research & Care
- Vol. 5 (1), e000320
- https://doi.org/10.1136/bmjdrc-2016-000320
Abstract
To evaluate the performance of the FreeStyle Libre Flash continuous glucose monitoring (FSL-CGM) system against established central laboratory methods. 20 subjects (8 type 1 diabetes mellitus, 12 type 2 diabetes mellitus) were analyzed. FSL-CGM sensor measurements (inserted in arm and abdomen) were compared with capillary blood glucose results analyzed with StatStrip as semigold standard. The glucose response after a standardized oral glucose load was measured by FSL-CGM and capillary samples analyzed by perchloric acid hexokinase (PCA-HK) method, StatStrip and FSL test strip (FSLC), and a commonly used CGM system (iPro2). FSL-CGM arm sensor readings showed 85.5% of paired readings falling within Clarke Error Grid (ISO 15197:2013) zone A when compared with StatStrip. For FSL-CGM abdomen and FSLC, these percentages were 64% and 98%, respectively. The overall correlation of FSL-CGM in the arm and the StatStrip indicates a performance with lower results with the FSL-CGM in the arm than expected based on the StatStrip in the lower glucose ranges, and higher results than expected in the higher ranges. Following a standardized glucose load, a slower rise in glucose level was observed for FSL-CGM arm as compared with PCA-HK, StatStrip, FSLC, and iPro2 during the first 45–60 min after glucose load ingestion. Certain matters need attention while using the FSL-CGM in daily life including the observed lower values in the lower ranges, and the underestimation of the effect of a meal on glucose response. These effects of such deviations can partly be overcome by optimizing the available user instructions. TC5348; results.Keywords
This publication has 27 references indexed in Scilit:
- Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluationHealth Technology Assessment, 2016
- Accuracy of Continuous Glucose Monitoring During Three Closed-Loop Home Studies Under Free-Living ConditionsDiabetes Technology & Therapeutics, 2015
- Accuracy of two continuous glucose monitoring systems: a head‐to‐head comparison under clinical research centre and daily life conditionsDiabetes, Obesity and Metabolism, 2014
- Continuous Glucose Monitoring in the Subcutaneous Tissue over a 14-Day Sensor Wear PeriodJournal of Diabetes Science and Technology, 2013
- Assessing the Quality of Publications Evaluating the Accuracy of Blood Glucose Monitoring SystemsDiabetes Technology & Therapeutics, 2013
- Use of Continuous Glucose Monitoring in the Detection and Prevention of HypoglycemiaJournal of Diabetes Science and Technology, 2007
- Evaluating the Clinical Accuracy of Two Continuous Glucose Sensors Using Continuous Glucose–Error Grid AnalysisDiabetes Care, 2005
- Continuous Glucose MonitoringDiabetes Care, 2005
- Evaluating Clinical Accuracy of Systems for Self-Monitoring of Blood GlucoseDiabetes Care, 1987
- The Rapid, Enzymatic Determination of Glucose in Hemolysatescclm, 1970